在其他近期新闻中，Quanterix Corporation正面临重要股东对其与Akoya Biosciences拟议合并的反对。持有Quanterix 1.5%股份的Tikvah Management LLC和持有5.9%股份的Kent Lake PR LLC已公开表示他们将投票反对合并。两家公司都表达了对Quanterix被低估和财务影响的担忧。Tikvah ...

Investing.com — 周一，Canaccord Genuity维持对Akoya Biosciences Inc (NASDAQ: AKYA )股票的"持有"评级，目标价稳定在3.50美元。根据 InvestingPro 数据，分析师对AKYA的目标价范围从2.40美元到5.00美元不等，最近有三位分析师上调了其盈利预期。Canaccord ...

2025年3月25日， Akoya Biosciences（AKYA）披露2笔公司内部人交易情况。董事McKelligon Brian于2025年3月23日卖出7550股。 2025年3月25日 董事 McKelligon Brian 2025年3月23日 卖出 7550 1.70 1.28万 2025年3月25日 高管 Ramachandran Niro Ph.D 2025年3月23日 卖出 2 ...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report)‘s stock had its “equal weight” rating restated by stock analysts at ...

Fintel reports that on March 25, 2025, Stephens & Co. downgraded their outlook for Akoya Biosciences (NasdaqGS:AKYA) from ...

Stephens & Co.：下调Akoya Biosciences(AKYA.US)评级，由增持调整至持股观望评级, 目标价由3.50美元调整至1.80美元。 Akoya Biosciences（AKYA.US）公司简介 ...

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a large decline in short interest in March. As of March 15th, there was short interest totalling 2,490,000 shares, a decline of 30.8% from ...

Stephens downgraded Akoya Biosciences (AKYA) to Equal Weight from Overweight with a price target of $1.80, down from $3.50, given the pending ...

This article was originally published on Quiver News, read the full story. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of ...

In a report released today, William Bonello from Craig-Hallum maintained a Hold rating on Akoya Biosciences (AKYA – Research Report). The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...